2020

Year in Review

In a year of unprecedented hardship we witnessed never-before-seen speeds of innovation and levels of collaboration in the global healthcare community.

 

As we reflect on the past year, we are proud to share highlights from our team and portfolio who responded, contributed, and innovated throughout it all.

Notable Highlights

Initiated world’s first controlled clinical trial for a CRISPR-enhanced bacteriophage therapy

Granted FDA clearance for atrial fibrillation and heart murmur AI algorithms for use with its digital stethoscopes

 

Excision's technology inventor, Jennifer Doudna, wins 2020 Nobel Prize in Chemistry

Helped more than 165,000 patients get access to on-demand virtual care

Executed one of the year's most successful direct listings on NASDAQ (PLTR: Mkt Cap $54B)

Demonstrated high sensitivity and specificity in multiomics blood test for detecting early-stage colorectal cancer

Reached a major R&D breakthrough with the discovery of a subset of plant-derived proteins that work comparably to collagen, enabling the team to scale production

Reached space with Rocket 3.2, its second launch attempt

 

11

New Companies Joined Our Portfolio

Including incubation and launch of 3 startups

activ-surgical-logo.png
replay-logo.png

Stealth Health

COMING SOON

Stealth Health

COMING SOON

Stealth Fintech

COMING SOON

​New Funding Rounds

17 

Second Front: Seed

Replay Therapeutics:

Cvt Note

Outpace Bio: 

Series A

Locus Biosciences:

Cvt Note

Lemonaid:
Series B